Examples of 'ongoing phase' in a sentence
Meaning of "ongoing phase"
ongoing phase: This phrase refers to a stage or period that is currently in progress and has not yet been completed. It implies continuity or persistence in the development or execution of a project, process, or initiative
                                                                                            How to use "ongoing phase" in a sentence
                                        
                                        Basic
                                    
                                    
                                        
                                        Advanced
                                    
                                
                                
                                
                                ongoing phase
                                
                                
                                
                            
                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    This ongoing phase ensures the availability and security of the use case over its lifetime.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    There are currently seven other ongoing phase II investigations.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The last ongoing phase II investigation concerns the in the telecommunications market.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    There are currently three other ongoing phase II merger investigations.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    There is an ongoing phase II trial studying the effect of entinostat on Hodgkin 's lymphoma.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    An impact assessment at the end of the ongoing phase II is being undertaken.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The ongoing phase value P is a piecewise-linear approximation of a linear phase increase.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Addition of new sites in ongoing Phase III osteonecrosis trial.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The ongoing phase I clinical trial of NIR-PIT may help answer that question.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The Joint Mission continues with ongoing phase II inspection and verification activities.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The ongoing Phase III trial, called GLOBE, also is a head-to-head comparision against lamivudine.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The Joint Mission continued with ongoing phase II inspection and verification activities.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The ongoing Phase 3 program includes two studies, APOLLO and LUNAR.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The planned US study design is similar to the ongoing Phase III trial in Europe.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    In an ongoing phase IIa clinical study IMAB362 is given repetitively.
                                        
                                    See also
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    These results support continuation of the ongoing Phase 1 study.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    According to the results of the ongoing phase IIa, at least two scenarios are possible.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    We look forward to the results of the ongoing Phase 3 study . ".
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Currently, there are two ongoing phase II merger investigations.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The funds will support the ongoing Phase 3 stage for NiCord.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Additionally, they have an ongoing Phase 2 clinical trial for DMD.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    On track ongoing ongoing Phase III 1.
                                        
                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The companies will share results of several ongoing Phase 3 studies in various disclosures in 2015.
                                        
                                    You'll also be interested in:
                                        Examples of using Phase
                                        
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         Show more
                                                        
                                                                                                            
                                                
                                                                                    
                                        
                                            Show more
                                    
                                                                    
                                                            The first phase evolved over millennia
                                                        
                                                    
                                                            Review of the execution of the design phase
                                                        
                                                    
                                                            The results of phase two have been amazing
                                                        
                                                    
                                        Examples of using Ongoing
                                        
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         
                                                        
                                                                                                            
                                                
                                                                                            
                                                    
                                                        
                                                        
                                                    
                                                         Show more
                                                        
                                                                                                            
                                                
                                                                                    
                                        
                                            Show more
                                    
                                                            
                                                            Discussions are ongoing on the implementation of the recommendations
                                                        
                                                    
                                                            Management oversees capital adequacy on an ongoing basis
                                                        
                                                    
                                                            Ongoing synthesis of NAPAs as more NAPAs are submitted